![FDA says benefits outweigh risks for Pfizer/BioNTech Covid-19 vaccine in children](https://thepeninsulaqatar.com/uploads/2021/10/23/post_main_cover/7e28817fb57fc888a6030255c781db631b6cf1c9.jpeg)
FDA says benefits outweigh risks for Pfizer/BioNTech Covid-19 vaccine in children
The Peninsula
New York: Scientists at the US Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer/BioNTech COVID-19 vaccine to 5 to 11 year olds clearly outweigh the risks of rare cases of heart inflammation.
Earlier on Friday, the vaccine makers said their shot showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old.
The details were in briefing documents published ahead of a meeting of a panel of outside experts scheduled to vote on Tuesday whether to recommend the FDA authorize the shots for the young age group.
More Related News